Skip to main content

Table 7 Values of the metabolic parameters on predicting tumor pathological complete response

From: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer

Metabolic parameters

Tumor with PCR(n = 18)

Tumor without PCR(n = 33)

p value

Scan-1

SULmax

11.6 ± 5.8

11.4 ± 4.3

0.921

SULpeak

9.8 ± 5.0

9.9 ± 4.1

0.948

MTV

40.4 ± 53.0

26.7 ± 24.2

0.657

TLG

280.7 ± 432.4

197.5 ± 201.2

0.937

T/N ratio

5.3 ± 2.0

5.5 ± 2.8

0.806

Scan-2

SULmax

1.9 ± 0.7

7.6 ± 6.8

< 0.001

SULpeak

1.5 ± 0.6

6.2 ± 5.8

< 0.001

MTV

6.2 ± 12.1

10.9 ± 15.8

0.007

TLG

15.2 ± 50.0

72.4 ± 154.8

< 0.001

T/N ratio

0.8 ± 0.3

3.2 ± 3.2

0.003

The percentage changes(Δ%) between scan-1 and scan-2

ΔSULmax%

-81.0 ± 9.5

-32.5 ± 43.7

< 0.001

ΔSULpeak%

-81.9 ± 10.4

-35.4 ± 40.6

< 0.001

ΔMTV%

-81.3 ± 21.5

-59.3 ± 42.2

0.016

ΔTLG%

-95.2 ± 7.2

-65.4 ± 44.5

< 0.001

ΔT/N ratio%

-80.3 ± 7.4

-40.4 ± 40.3

< 0.001